These data suggested that SKPin C1 increased the population of mitotic cells in VHL-deficient RCC cells and AURKA/B-CDC25C-CDK1/cyclin B pathway was persistently up-regulated in VHL-deficient RCC cells upon treatment with SKPin C1. This evidence concerns the gene CDK1 and renal cell carcinoma.